KRYSTAL GONZALEZ

HIALEAH, FL NPI 1497499388

General Payments — all program years on this page

$587.45

  • Category: General Payments
  • Program years: PY2024
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $587.45 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $587.4521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $587.4521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1118899576 Otsuka America Pharmaceutical, Inc. $18.06 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899578 Otsuka America Pharmaceutical, Inc. $25.37 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899580 Otsuka America Pharmaceutical, Inc. $24.16 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899582 Otsuka America Pharmaceutical, Inc. $24.16 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899584 Otsuka America Pharmaceutical, Inc. $19.53 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899586 Otsuka America Pharmaceutical, Inc. $24.16 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899588 Otsuka America Pharmaceutical, Inc. $24.16 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899590 Otsuka America Pharmaceutical, Inc. $28.19 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118899592 Otsuka America Pharmaceutical, Inc. $27.87 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143232632 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.11 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143232636 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $125.00 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150831824 Neurocrine Biosciences, Inc. $27.78 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150832200 Neurocrine Biosciences, Inc. $27.65 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150837906 Neurocrine Biosciences, Inc. $25.74 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150841996 Neurocrine Biosciences, Inc. $24.33 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150849450 Neurocrine Biosciences, Inc. $22.43 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150873626 Neurocrine Biosciences, Inc. $15.47 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151476418 Teva Pharmaceuticals USA, Inc. $24.16 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151476436 Teva Pharmaceuticals USA, Inc. $18.79 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151476452 Teva Pharmaceuticals USA, Inc. $23.94 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151476476 Teva Pharmaceuticals USA, Inc. $15.39 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.